Louis Garnier François Ducray Clotilde Verlut Marcella-Ionela Mihai Françoise Cattin Antoine Petit Elsa Curtit
10.3389/fonc.2019.00177
Front Oncol
2019 Mar 26;9:177.
braf central nervous system tumor ganglioglioma safety spinal cord tumor regression vemurafenib
CC BY
https://pubmed.ncbi.nlm.nih.gov/30984614/
Case Reports
PMC6448025
30984614
Prolonged Response Induced by Single Agent Vemurafenib in a BRAF V600E Spinal Ganglioglioma: A Case Report and Review of the Literature
2019